IP Library Granted Patent US 10,695,583
Granted Patent B2
US 10,695,583 · App. 16/217,417 · Granted Jun 30, 2020

Systems and methods for use in emission guided radiation therapy

Inventors: Samuel Mazin (Menlo Park, CA); Akshay Nanduri (San Francisco, CA)
Assignee: RefleXion Medical, Inc.
A61N5/1065A61B5/055A61B6/032A61B6/037A61B6/12A61B6/469A61B6/54A61N5/1039A61N5/1042A61N5/1048A61N5/1067A61N5/1081G01T1/2907G01T1/2985A61B2090/374A61B2090/3762A61N5/1001A61N5/1045A61N2005/1074A61N2005/1087
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,695,583
App. No.
16/217,417
Granted
Jun 30, 2020
Kind
B2
Abstract

Described herein are systems and methods for positioning a radiation source with respect to one or more regions of interest in a coordinate system. Such systems and methods may be used in emission guided radiation therapy (EGRT) for the localized delivery of radiation to one or more patient tumor regions. These systems comprise a gantry movable about a patient area, where a plurality of positron emission detectors, a radiation source are arranged movably on the gantry, and a controller. The controller is configured to identify a coincident positron annihilation emission path and to position the radiation source to apply a radiation beam along the identified emission path. The systems and methods described herein can be used alone or in conjunction with surgery, chemotherapy, and/or brachytherapy for the treatment of tumors.

Claims (44)

1. A system for hybrid radiation therapy, the system comprising:

a gantry;

a radiation source mounted on the gantry;

positron annihilation emission detectors mounted on the gantry, wherein the positron annihilation emission detectors are configured to detect one or more positron annihilation emission paths; and

a controller in communication with the radiation source and the positron annihilation emission detectors, the controller configured to deliver radiation to a patient target region according to an intensity modulated radiotherapy (IMRT) treatment plan or an emission guided radiotherapy (EGRT) treatment plan,

wherein the controller is further configured to determine whether to deliver radiation using the radiation source according to the IMRT treatment plan or the EGRT treatment plan by determining whether the one or more detected positron annihilation emission paths provide sufficient positron annihilation emission path data for delivering radiation according to the EGRT treatment plan.

2. The system of claim 1 , wherein the controller is configured to deliver radiation according to the EGRT treatment plan by:

determining whether a detected positron annihilation emission path intersects the patient target region, and

if the detected positron annihilation emission path intersects the patient target region, positioning the radiation source with respect to the detected positron annihilation emission path.

3. The system of claim 2 , wherein positioning the radiation source with respect to the detected positron annihilation emission path comprises aligning the radiation source along the detected positron annihilation emission path.

4. The system of claim 2 , wherein the detected positron annihilation emission path is defined by a pair of photons emitted by a positron annihilation event, and wherein determining whether the detected positron annihilation emission path intersects the patient target region comprises:

calculating a time difference between the detection of each of the photons in the pair of photons;

computing a location of the positron annihilation event based on the calculated time difference, wherein the location computation has an estimation error;

extending a boundary of the patient target region according to the estimation error; and

determining whether the location of the positron annihilation event is located within the extended boundary of the patient target region.

5. The system of claim 1 , wherein determining whether there is sufficient positron annihilation emission path data comprises determining a signal strength of the one or more detected positron annihilation emission paths.

6. The system of claim 1 , wherein positron annihilation emission path data comprises location data.

7. The system of claim 6 , wherein location data comprises positron annihilation event location data.

8. The system of claim 1 , wherein determining whether to deliver radiation according to the IMRT treatment plan or the EGRT treatment plan uses a pre-determined model stored in the controller.

9. The system of claim 1 , wherein the controller is configured to deliver radiation according to the IMRT treatment plan by instructing the radiation source to generate conformal radiation doses to the patient target region.

10. The system of claim 9 , wherein delivering radiation according to the IMRT treatment plan comprises delivering radiation to the entire patient target region.

11. The system of claim 1 , wherein the controller is further configured to deliver radiation according to the IMRT treatment plan for a first portion of a radiotherapy session and to deliver radiation according to the EGRT treatment plan for a second portion of the radiotherapy session.

12. The system of claim 1 , wherein the gantry is configured to position the radiation source at different gantry angles, and the controller is further configured to instruct the radiation source to deliver radiation according to the IMRT treatment plan and to deliver radiation according to the EGRT treatment plan at each gantry angle.

13. The system of claim 1 , wherein the gantry is configured to position the radiation source at a first gantry angle and a second gantry angle, and the controller is further configured to deliver radiation according to the IMRT treatment plan when the radiation source is positioned at the first gantry angle and to deliver radiation according to the EGRT treatment plan at the second gantry angle.

14. A method for hybrid radiation therapy, the method comprising:

detecting one or more positron annihilation emission paths from a patient using positron emission detectors mounted on a gantry;

determining whether to deliver radiation according to an intensity modulated radiotherapy (IMRT) treatment plan or an emission guided radiotherapy (EGRT) treatment plan by determining whether the one or more detected positron annihilation emission paths provide sufficient positron annihilation emission path data for delivering radiation according to the EGRT treatment plan; and

delivering radiation to a patient target region according to the IMRT treatment plan or the EGRT treatment plan using a radiation source mounted on the gantry.

15. The method of claim 14 , wherein determining whether there is sufficient positron annihilation emission path data comprises determining a signal strength of the one or more detected positron annihilation emission paths.

16. The method of claim 14 , wherein positron annihilation emission path data comprises location data.

17. The method of claim 16 , wherein determining whether to deliver radiation according to the IMRT treatment plan or the EGRT treatment plan is based a pre-determined model stored in a controller.

18. The method of claim 14 , wherein delivering radiation to the patient target region according to the EGRT treatment plan comprises:

determining whether a detected positron annihilation emission path intersects the patient target region, and

if the detected positron annihilation emission path intersects the patient target region, positioning the radiation source with respect to the detected positron annihilation emission path.

19. The method of claim 18 , wherein positioning the radiation source comprises aligning the radiation source along the detected positron annihilation emission path.

20. The method of claim 18 , wherein the detected positron annihilation emission path is defined by a pair of photons emitted by a positron annihilation event, and wherein determining whether a detected positron annihilation emission path intersects the patient target region comprises:

calculating a time difference between the detection of each of the photons in the pair of photons;

computing a location of the positron annihilation event based on the calculated time difference, wherein the location computation has an estimation error;

extending a boundary of the patient target region according to the estimation error; and

determining whether the location of the positron annihilation event is within the extended boundary of the patient target region.

21. The method of claim 14 , wherein delivering radiation according to the IMRT treatment plan comprises generating conformal radiation doses to the patient target region using the radiation source.

22. The method of claim 14 , further comprising delivering radiation according to the IMRT treatment plan for a first portion of a radiotherapy session and delivering radiation according to the EGRT treatment plan for a second portion of the radiotherapy session.

23. The method of claim 14 , further comprising moving the gantry about the patient target region to position the radiation source at different gantry angles, and at each gantry angle, delivering radiation according to the IMRT treatment plan and delivering radiation according to the EGRT treatment plan.

24. The method of claim 14 , further comprising moving the gantry about the patient target region to position the radiation source at a first gantry angle and a second gantry angle, delivering radiation according to the IMRT treatment plan when the radiation source is positioned at the first gantry angle and delivering radiation according to the EGRT treatment plan when the radiation source is positioned at the second gantry angle.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jul 11, 2022
From: OXFORD FINANCE LLC
To: REFLEXION MEDICAL, INC.
Reel/Frame 060469/0862 →
SECURITY INTEREST Recorded Jul 11, 2022
From: REFLEXION MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 060619/0066 →
SECURITY INTEREST Recorded Apr 26, 2019
From: REFLEXION MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 049009/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2018
From: MAZIN, SAMUEL; NANDURI, AKSHAY
To: REFLEXION MEDICAL, INC.
Reel/Frame 047793/0028 →
Continuity (6)
Continuation 15684710 · Aug 23, 2017
Continuation 15499671 · Apr 27, 2017
Division 15047552 · Feb 18, 2016
Division 14007312
Provisional Application 61470432 · Mar 31, 2011
Related Publication 20190118001A1 · Apr 25, 2019
Cited By (4)
US 12,251,579 US 12,502,554 US 12,582,845 US 12,700,100